Home Your basket
• Oto-rhino-laryngology and...
   Price 10.50 €
• Toxic nodular goitre asso...
   Price 5.50 €
• Voice prostheses: long-te...
   Price 10.50 €
• Phoniatric management of ...
   Price 8.50 €
• Combined transoral and su...
   Price 10.50 €
• Migraine, neurone and ves...
   Price 5.50 €
• Recurrent mandibular amel...
   Price 12.50 €
• Influence of Platelet Ric...
   Price 10.50 €
• Diagnostic value of fine-...
   Price 8.50 €
• Evaluation of the handica...
   Price 10.50 €
• Cataract surgery and its ...
   Price 10.50 €
• Quality of life before an...
   Price 10.50 €
• Velo-pharyngeal incompete...
   Price 14.00 €
• Newborn and infant nasal ...
   Price 5.50 €
• Covering of parotid and c...
   Price 14.00 €
• Periphery, central and ps...
   Price 10.50 €
• The pedicled musculo-cuta...
   Price 8.50 €
• The symphonix symposium u...
   Price 8.50 €
• The prevention of voice d...
   Price 10.50 €
• Vocal effectiveness in sp...
   Price 10.50 €
• Supra and infra hyoid mid...
   Price 10.50 €
• External otitis...
   Price 8.50 €
• Late metastasis from rena...
   Price 8.50 €
• Formant structures of vow...
   Price 10.50 €
• Post-operative evaluation...
   Price 10.50 €
• Laryngeal schwannomas...
   Price 5.50 €
• Observational study to as...
   Price 14.00 €
• Vertebro and cranio veino...
   Price 14.00 €
• Research in cancer : adva...
   Price 5.50 €
• Benign tumors of the nasa...
   Price 14.00 €
• Analysis of the possibili...
   Price 8.50 €
• Fibrous dysplasia, a case...
   Price 10.50 €
• International Conference ...
   Price 5.50 €
• Carotid body paragangliom...
   Price 8.50 €

Total Order 330.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2008 o

CERVICO-FACIAL CARCINOLOGY

Sarcomatoid carcinomas of the upper airways


Authors : Oueslati Z, Ben Miled M, Hammoud M, Touati S, Lachkham A, Gamoudi A, Mokni N, El Benna F, Boussen H, El May A, Ladgham A. (Tunis)

Ref. : Rev Laryngol Otol Rhinol. 2008;129,3:191-195.

Article published in french
Downloadable PDF document french



Summary : Introduction: The sarcomatoid carcinoma of the superior aerodigestive tracts is a rare malignant tumour, which presents diagnostic and therapeutic challenges. Material and method: We report 11 cases of spindle cell carcinomas of the upper airways. Results: Sex-ratio was 10:1 and the mean age was 57.3 years (30 - 75 years). Nine patients were smokers and 4 presented with a history of radiation exposure. Tumoral locations were as follows: larynx: 6, hypopharynx: 1, oropharynx: 1, nasopharynx: 1, oral cavity: 2. Histological diagnosis in 3 cases required the use of immunohistochemical studies. Four patients were first seen at an advanced stage. This left 9 patients and among them 7 received a curative treatment: 5 by surgery alone, 1 by surgery and radiotherapy, 1 by radiotherapy, 1 by chemo-radiotherapy for the nasopharyngeal lesion and 1 by chemotherapy alone. Two patients died from their disease before treatment. With an average delay of 15.4 months, the rates of global survival and disease-free were 5/9 and 4/9 respectively. Conclusion: The sarcomatoid carcinoma of the upper airways is rare, but not unusual. Its diagnosis benefits from progresses in immunohistochemistry, but also from advances in the field of molecular biology. Its treatment and natural evolution remain controversial.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE